Shon Green

481 total citations
7 papers, 184 citations indexed

About

Shon Green is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shon Green has authored 7 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shon Green's work include CAR-T cell therapy research (3 papers), Cancer-related Molecular Pathways (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Shon Green is often cited by papers focused on CAR-T cell therapy research (3 papers), Cancer-related Molecular Pathways (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Shon Green collaborates with scholars based in United States and Australia. Shon Green's co-authors include Martin McMahon, Christy L. Trejo, Jingwei Lu, Javier F. Morales, Lucas H. Horan, Lianxing Liu, Yiyang Xu, Bryan Zimdahl, Pengbo Zhang and David M. Barrett and has published in prestigious journals such as Cancer Research, eLife and Molecular Therapy.

In The Last Decade

Shon Green

7 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shon Green United States	5	136	76	60	33	30	7	184
J.T. Greene United States	6	93 0.7×	67 0.9×	66 1.1×	36 1.1×	14 0.5×	11	169
Jiang Lv China	6	162 1.2×	63 0.8×	90 1.5×	41 1.2×	34 1.1×	8	225
Gustav Jonsson Austria	6	159 1.2×	60 0.8×	158 2.6×	21 0.6×	23 0.8×	10	268
Alexandra Cabanov United States	4	203 1.5×	81 1.1×	162 2.7×	25 0.8×	30 1.0×	7	273
Jonathan Boiarsky United States	3	157 1.2×	198 2.6×	82 1.4×	16 0.5×	26 0.9×	5	312
Ying Fang United States	11	214 1.6×	95 1.3×	129 2.1×	11 0.3×	30 1.0×	17	298
Aodrenn Spill Switzerland	4	241 1.8×	78 1.0×	137 2.3×	19 0.6×	68 2.3×	6	300
Adina Hughes United Kingdom	5	141 1.0×	93 1.2×	81 1.4×	15 0.5×	9 0.3×	11	204
Kassondra Meyer United States	9	269 2.0×	123 1.6×	96 1.6×	21 0.6×	15 0.5×	14	355
Zoran Gajic United States	6	95 0.7×	106 1.4×	54 0.9×	20 0.6×	14 0.5×	9	191

Countries citing papers authored by Shon Green

Since Specialization

Citations

This map shows the geographic impact of Shon Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shon Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shon Green more than expected).

Fields of papers citing papers by Shon Green

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shon Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shon Green. The network helps show where Shon Green may publish in the future.

Co-authorship network of co-authors of Shon Green

This figure shows the co-authorship network connecting the top 25 collaborators of Shon Green. A scholar is included among the top collaborators of Shon Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shon Green. Shon Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Green, Shon. (2024). Expanding CAR-engineered cell therapies into autoimmune diseases. Molecular Therapy. 32(11). 3768–3769. 1 indexed citations

2.

Veen, J. Edward van, Julia Boshuizen, Allison Landman, et al.. (2019). Mutationally-activated PI3’-kinase-α promotes de-differentiation of lung tumors initiated by the BRAFV600E oncoprotein kinase. eLife. 8. 13 indexed citations

3.

Xu, Yiyang, Zhiyuan Yang, Lucas H. Horan, et al.. (2018). A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release. Cell Discovery. 4(1). 62–62. 95 indexed citations

4.

Liu, Hong, Yiyang Xu, Jingyi Xiang, et al.. (2016). Abstract 2299: ET1402L1-CART, a T cell therapy targeting the intracellular tumor antigen AFP, demonstrates potent antitumor activity in hepatocellular carcinoma models. Cancer Research. 76(14_Supplement). 2299–2299. 1 indexed citations

5.

Shai, Anny, David Dankort, Joseph Juan, Shon Green, & Martin McMahon. (2015). TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung Tumorigenesis. Cancer Research. 75(15). 3167–3180. 14 indexed citations

6.

Green, Shon, Christy L. Trejo, & Martin McMahon. (2015). PIK3CAH1047R Accelerates and Enhances KRASG12D-Driven Lung Tumorigenesis. Cancer Research. 75(24). 5378–5391. 27 indexed citations

7.

Trejo, Christy L., Shon Green, Victoria Marsh, et al.. (2013). Mutationally Activated PIK3CAH1047R Cooperates with BRAFV600E to Promote Lung Cancer Progression. Cancer Research. 73(21). 6448–6461. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact